Boykin Curry - Triple Frond Partners
Period: Q1 2026
Portfolio date: 31 Mar 2026
No. of stocks: 12
Portfolio value: $962,895,000
Holding/activity history for Talecris Biotherapeutics Hld (TLCR)
| Period |
Shares |
% of Portfolio |
Activity |
% Change to Portfolio |
Reported Price |
Value |
Filing |
| 2011 Q2 |
0 |
0.00 |
Sell 100.00%
|
7.91 |
|
|
SEC |
| 2011 Q1 |
800,000 |
7.91 |
|
|
$26.80 |
$21,440,000 |
SEC |
| 2010 Q4 |
800,000 |
8.77 |
Add 40.35%
|
2.52 |
$23.30 |
$18,640,000 |
SEC |
| 2010 Q3 |
570,000 |
4.97 |
Buy
|
4.97 |
$22.88 |
$13,042,000 |
SEC |